Skip to main content
Signal8

Parabilis Medicines, Inc. (PBLS)

Sector: Pharmaceutical Preparations

Industry: Biotechnology

Parabilis Medicines, Inc. logo

Parabilis Medicines, Inc.

NASDAQ:PBLSHealthcare
+0.49%$28.67
Mkt Cap$3.54B
Float101.16M
O/S123.53M
VOL12K sh
$ Vol$350K
RVOL0.01×
Inst Own81.0%
Dilution
Parabilis Medicines, Inc. logoNASDAQ:PBLS$28.67+0.49%
Historical Data
DateOpenHighLowCloseVolume
Nov 9, 202629.2129.5528.3628.9312,142
Nov 6, 202627.8828.8727.1128.53629,325
Nov 5, 202630.1330.1327.5527.88920,738
Nov 4, 202630.0030.8328.7030.36842,967
Nov 3, 202628.2529.7327.9029.25519,455
Nov 2, 202628.1328.5526.8727.25702,260
Oct 30, 202628.5928.7427.4828.32813,967
Oct 29, 202628.3230.0827.1928.70844,732
Oct 28, 202626.2428.2926.1428.171,397,331
Oct 27, 202625.0027.3624.7526.511,572,918
Oct 26, 202625.0125.5923.0625.031,427,695
Oct 23, 202626.7426.7423.9624.441,820,958
Oct 22, 202628.0328.2926.5826.92911,949
Oct 21, 202627.3928.4826.4027.851,392,000
Oct 20, 202625.4027.9324.4427.081,495,412
Oct 19, 202622.9826.2422.9825.352,142,691
Oct 16, 202625.3925.7022.6622.751,115,325
Oct 15, 202625.7626.4324.8025.18955,214
Oct 14, 202627.0027.3925.7325.89764,911
Oct 13, 202629.4529.5026.7226.851,187,838
Analyst Coverage
Analyst Coverage
Price Target (median, last 90d)
$40.00+39.5%
Low $40High $40
Ratings
N/A
Insider Trades
InsiderTypeShares
Tendler Craig profile photoTendler CraigGrant/Award20.3K
RA CAPITAL MANAGEMENT, L.P. profile photoRA CAPITAL MANAGEMENT, L.P.Purchase47.3K
RA CAPITAL MANAGEMENT, L.P. profile photoRA CAPITAL MANAGEMENT, L.P.Purchase6.5K
RA CAPITAL MANAGEMENT, L.P. profile photoRA CAPITAL MANAGEMENT, L.P.Purchase37.7K
RA CAPITAL MANAGEMENT, L.P. profile photoRA CAPITAL MANAGEMENT, L.P.Purchase21.7K
RA CAPITAL MANAGEMENT, L.P. profile photoRA CAPITAL MANAGEMENT, L.P.Purchase98.4K
Shareholders
81.0%
Institutional
(100)
0.1%
Insiderⓘ
(2)
0.0%
5%+ Owners
(0)
18.9%
Unattributed (incl. retail)ⓘ
Institutional81.0%
Insider0.1%
Unattributed (incl. retail)18.9%
Sources: 13F, Form 4O/S: 123.5M · checked 9 Nov 2026 · market-data provider
Insiders & Institutional Holders

Insiders

Top institutional holders

About

Fog Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company.

It discovers and develops cell-penetrating miniproteins (CPMPs), which are specifically designed to target cancer-causing proteins inside cancer cells and neutralize them.

The company was founded by Gregory L. Verdine, WeiQing Zhou and David Philip Lane in 2015 and is headquartered in Cambridge, MA.

Key Metrics
Market Cap$3.54B
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership81.02%

based on 123.53M shares outstanding

SectorHealthcare
IndustryBiotechnology
ExchangeNASDAQ
CountryUSUS
IPO DateJun 10, 2026
Shares Outstanding123.53M
Authorized Shares
Float101.16M
52-Week Range
$24.51$42.49
$28.67(23rd percentile)
Volume
Average Daily Volume1.08M
12.14K today vs 1.08M avg(-99%)

30d Avg

1.08M

60d Avg

1.18M

90d Avg

923.92K

Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...